{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 3.8596303056692705e-05, "B": 5.9604641222676946e-08, "C": 4.76836959251159e-07, "D": 1.1725283861160278, "E": 0.0}, "ranked_options": [{"letter": "E", "text": "Doxorubicin", "avg_nll": 0.0}, {"letter": "B", "text": "Rituximab", "avg_nll": 5.9604641222676946e-08}, {"letter": "C", "text": "Cyclophosphamide", "avg_nll": 4.76836959251159e-07}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 3.8596303056692705e-05}, {"letter": "D", "text": "Vincristine", "avg_nll": 1.1725283861160278}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 4.519676208496094, "B": 1.1011401414871216, "C": 0.8353265523910522, "D": 2.25034499168396, "E": 3.0168254375457764}, "ranked_options": [{"letter": "C", "text": "She has a mood disorder.", "avg_nll": 0.8353265523910522}, {"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 1.1011401414871216}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 2.25034499168396}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 3.0168254375457764}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 4.519676208496094}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 3.928351879119873, "B": Infinity, "C": Infinity, "D": 12.971942901611328, "E": 3.545670986175537}, "ranked_options": [{"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 3.545670986175537}, {"letter": "A", "text": "Multiple sclerosis", "avg_nll": 3.928351879119873}, {"letter": "D", "text": "Brain abscess", "avg_nll": 12.971942901611328}, {"letter": "B", "text": "Dementia", "avg_nll": null}, {"letter": "C", "text": "Parkinson", "avg_nll": null}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 3.677492380142212, "B": 3.150036573410034, "C": 4.029609680175781, "D": 5.885527610778809, "E": 5.658938884735107}, "ranked_options": [{"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 3.150036573410034}, {"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 3.677492380142212}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 4.029609680175781}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 5.658938884735107}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 5.885527610778809}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 8.316725730895996, "B": 9.22661304473877, "C": 8.904556274414062, "D": 3.8976690769195557, "E": 7.6772356033325195}, "ranked_options": [{"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 3.8976690769195557}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 7.6772356033325195}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 8.316725730895996}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 8.904556274414062}, {"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 9.22661304473877}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 5.988039970397949, "B": 5.919222831726074, "C": 1.4523817300796509, "D": 3.7822952270507812, "E": 4.2998366355896}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 1.4523817300796509}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 3.7822952270507812}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 4.2998366355896}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 5.919222831726074}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 5.988039970397949}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 5.111950874328613, "B": 5.510856628417969, "C": 3.6736502647399902, "D": 6.6524553298950195, "E": 7.31719446182251}, "ranked_options": [{"letter": "C", "text": "Optiray 320", "avg_nll": 3.6736502647399902}, {"letter": "A", "text": "Omnipaque 320", "avg_nll": 5.111950874328613}, {"letter": "B", "text": "Imeron 400", "avg_nll": 5.510856628417969}, {"letter": "D", "text": "Gadovist", "avg_nll": 6.6524553298950195}, {"letter": "E", "text": "Xenetix 350", "avg_nll": 7.31719446182251}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 5.023279666900635, "B": 3.879467248916626, "C": 5.082442283630371, "D": 5.432997703552246, "E": 4.960394382476807}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 3.879467248916626}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 4.960394382476807}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 5.023279666900635}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 5.082442283630371}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 5.432997703552246}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 2.9538497924804688, "B": 5.108009338378906, "C": 2.1050281524658203, "D": 3.8916847705841064, "E": 5.13563346862793}, "ranked_options": [{"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 2.1050281524658203}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 2.9538497924804688}, {"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 3.8916847705841064}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 5.108009338378906}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 5.13563346862793}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 3.648257255554199, "B": 3.5356242656707764, "C": 3.7602813243865967, "D": 3.0563902854919434, "E": 3.5637238025665283}, "ranked_options": [{"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 3.0563902854919434}, {"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 3.5356242656707764}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 3.5637238025665283}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 3.648257255554199}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 3.7602813243865967}], "correct_answer_letter": "B", "error": null, "method": "local"}
